134 related articles for article (PubMed ID: 24990726)
1. Stem cells: Hope on the line.
Hayden EC
Nature; 2014 Jul; 511(7507):19-21. PubMed ID: 24990726
[No Abstract] [Full Text] [Related]
2. Wind-down of stem-cell institute leaves a void.
Loring JF
Nature; 2019 Aug; 572(7768):155. PubMed ID: 31391566
[No Abstract] [Full Text] [Related]
3. California Institute for Regenerative Medicine: accelerating stem cell therapies in California and beyond.
Trounson A
Stem Cells Transl Med; 2012 Jan; 1(1):6-8. PubMed ID: 23197633
[No Abstract] [Full Text] [Related]
4. California's vote to revive controversial stem-cell institute sparks debate.
Subbaraman N
Nature; 2020 Nov; 587(7835):535. PubMed ID: 33199902
[No Abstract] [Full Text] [Related]
5. Stem cells: The impatient advocate.
Dolgin E
Nature; 2010 Dec; 468(7324):620-3. PubMed ID: 21124428
[No Abstract] [Full Text] [Related]
6. Stem-cell agency faces budget dilemma.
Hayden EC
Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
[No Abstract] [Full Text] [Related]
7. Stem cells: the 3-billion-dollar question.
Hayden EC
Nature; 2008 May; 453(7191):18-21. PubMed ID: 18461716
[No Abstract] [Full Text] [Related]
8. Alan Trounson, CIRM’s departed president: surprises, optimism, malaise.
Parson AB
Cell Stem Cell; 2014 Oct; 15(4):403-5. PubMed ID: 25405247
[No Abstract] [Full Text] [Related]
9. UK launches a new centre of excellence for stem cell research.
Qadir Z
Lancet; 2012 Aug; 380(9841):549. PubMed ID: 22891371
[No Abstract] [Full Text] [Related]
10. Regenerative medicine. CIRM: the good, the bad, and the ugly.
Miller G
Science; 2010 Dec; 330(6012):1742-3. PubMed ID: 21205649
[No Abstract] [Full Text] [Related]
11. Open for business.
Nature; 2007 Mar; 446(7133):232. PubMed ID: 17361139
[No Abstract] [Full Text] [Related]
12. The NIH and the regenerative medicine field.
Rao M
Regen Med; 2012 Mar; 7(2):129-31. PubMed ID: 22397601
[No Abstract] [Full Text] [Related]
13. The international translational regenerative medicine center.
Alexis Mde V; Grinnemo KH; Jove R
Regen Med; 2012 Nov; 7(6 Suppl):74-5. PubMed ID: 23210815
[TBL] [Abstract][Full Text] [Related]
14. Collaborations in stem cell science.
Thomas J
Regen Med; 2012 Nov; 7(6 Suppl):71-2. PubMed ID: 23210814
[TBL] [Abstract][Full Text] [Related]
15. Local and global returns from research in stem cells: the case of the California Institute for Regenerative Medicine.
Alberro J
Regen Med; 2012 Jul; 7(4):605-13. PubMed ID: 22817632
[TBL] [Abstract][Full Text] [Related]
16. Global update: Scotland.
Courtney A
Regen Med; 2011 Nov; 6(6 Suppl):150-2. PubMed ID: 21999279
[TBL] [Abstract][Full Text] [Related]
17. The proceedings of the California Stem Cell Agency.
Feigal EG; DeWitt ND
Stem Cells Transl Med; 2014 Jun; 3(6):671-2. PubMed ID: 24771394
[TBL] [Abstract][Full Text] [Related]
18. Global update: England and Wales.
Ilic D
Regen Med; 2011 Nov; 6(6 Suppl):144-7. PubMed ID: 21999278
[TBL] [Abstract][Full Text] [Related]
19. How California Institute for Regenerative Medicine research programs support science and regulatory policy.
Lomax GP; DeWitt ND; Millan MT; Feigal EG
Stem Cells Transl Med; 2014 Jun; 3(6):673-4. PubMed ID: 24771395
[TBL] [Abstract][Full Text] [Related]
20. California prepares to roll out stem-cell funding.
Dalton R
Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
